Tu1052 A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of TAK-438 (10 mg or 20 mg Once-Daily) Compared to Lansoprazole (15 mg Once-Daily) in a 24-Week Maintenance Treatment for Healed Erosive Esophagitis

✍ Scribed by Umegaki, Eiji; Iwakiri, Katsuhiko; Hiramatsu, Naoki; Sakurai, Yuuichi; Hori, Tetsuharu; Kudou, Kentarou; Nishimura, Akira; Ashida, Kiyoshi

• Book ID: 122300348
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 390 KB
• Volume: 146
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/S0016-5085(14)62675-5